Kolexia
Palmieri Lola-Jade Gastro-entérologie
Palmieri Lola-Jade
Gastro-entérologie
Institut Bergonié
Bordeaux, France
93 Activités
608 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Tumeurs neuroendocrines Carcinomes Diarrhée Tumeurs de l'oesophage Tumeurs du pancréas Tumeurs de l'estomac Cholangiocarcinome

Collaborateurs

Voir plus
Coriat Romain
Coriat Romain
Hôpital Cochin, Paris, France
Dermine Solene
Dermine Solene
Hôpital Beaujon, Clichy, France
Pernot Simon
Pernot Simon
Institut Bergonié, Bordeaux, France
Chaussade Stanislas
Chaussade Stanislas
Hôpital Cochin, Paris, France

Industries

Voir plus
Servier
19 collaboration(s)
Dernière en 2023
Amgen
13 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2021
Ipsen
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should mutation research be recommended in everyday practice?
Therapeutic advances in gastroenterology   17 janvier 2024
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Molecular cancer   04 novembre 2023
1634P Extensive molecular profiling of KRAS wild-type versus KRAS mutant pancreatic ductal adenocarcinoma on 233 patients
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
SO-1 A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH1 and IDH2, as monotherapy and in combination with cisplatin and gemcitabine in advanced IDH-mutant cholangiocarcinoma
Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023   01 juin 2023
Chemotherapy-induced ileitis associated or not with colitis in digestive oncology patients: An AGEO multicentre study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   10 avril 2023
#MARSBLEU Retrouvez l'émission... - Institut ... - Facebook
Facebook   24 mars 2023
Oesogastric cancer - new therapeutic targets.
Bulletin du cancer   10 novembre 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
International journal of cancer   14 juillet 2022
Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM).
2022 ASCO Annual Meeting I   02 juin 2022
REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the oesophageal or gastric carcinoma (OGC) cohort.
2022 ASCO Annual Meeting I   02 juin 2022